Oncologist-approved cancer information from the American Society of Clinical Oncology
Printer Friendly
Download PDF

Carcinoid Tumor

This section has been reviewed and approved by the Cancer.Net Editorial Board, 3/2014
Latest Research

ON THIS PAGE: You will read about the scientific research being done now to learn more about this type of tumor and how to treat it. To see other pages in this guide, use the colored boxes on the right side of your screen, or click “Next” at the bottom.

Doctors are working to learn more about carcinoid tumors, ways to prevent them, how to best treat them, and how to provide the best care to people diagnosed with this disease. The following areas of research may include new options for patients through clinical trials. Always talk with your doctor about the diagnostic and treatment options best for you.

New treatment approaches. Currently, many clinical trials for carcinoid tumors are studying new drugs and drug combinations. This includes the approaches of targeted therapy and immunotherapy as described in the Treatment Options section.

Genetics. As outlined in the Risk Factors section, family history of MEN1 may play a role in an individual’s risk level for developing a carcinoid tumor. Researchers are investigating MEN1 to learn more about this hereditary risk.

Supportive care. Clinical trials are underway to find better ways of reducing symptoms and side effects of current carcinoid tumor treatments in order to improve patients’ comfort and quality of life.

Looking for More About the Latest Research?

If you would like additional information about the latest areas of research regarding carcinoid tumor, explore these related items that take you outside of this guide:

To continue reading this guide, choose “Next” (below, right) to see a section about coping with the symptoms of the disease or the side effects of its treatment. Or, use the colored boxes located on the right side of your screen to visit any section.

© 2005-2014 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.

Connect With Us: